Asthika Goonewardene
Stock Analyst at Truist Securities
(1.30)
# 3,429
Out of 4,842 analysts
95
Total ratings
36.47%
Success rate
-15.37%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Asthika Goonewardene
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MRSN Mersana Therapeutics | Maintains: Buy | $9 → $10 | $0.37 | +2,632.99% | 4 | May 16, 2025 | |
| LEGN Legend Biotech | Maintains: Buy | $88 → $71 | $28.29 | +150.97% | 2 | May 14, 2025 | |
| ALLO Allogene Therapeutics | Maintains: Buy | $14 → $10 | $1.14 | +777.19% | 7 | May 14, 2025 | |
| AUTL Autolus Therapeutics | Maintains: Buy | $11 → $10 | $1.65 | +506.06% | 4 | Apr 1, 2025 | |
| GMAB Genmab | Maintains: Buy | $50 → $45 | $21.19 | +112.36% | 14 | Mar 11, 2025 | |
| IOVA Iovance Biotherapeutics | Maintains: Buy | $25 → $15 | $1.75 | +757.14% | 6 | Mar 3, 2025 | |
| CRGX CARGO Therapeutics | Downgrades: Hold | $32 → $7 | $4.14 | +69.29% | 3 | Jan 30, 2025 | |
| EXEL Exelixis | Maintains: Buy | $42 → $43 | $42.41 | +1.39% | 8 | Jan 27, 2025 | |
| IGMS IGM Biosciences | Maintains: Hold | $12 → $2 | $1.23 | +62.60% | 8 | Jan 10, 2025 | |
| BNTX BioNTech SE | Initiates: Buy | $172 | $97.53 | +76.36% | 1 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $26.04 | +34.41% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $87 → $136 | $61.17 | +122.33% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $83 → $97 | $108.44 | -10.55% | 1 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $15 | $0.92 | +1,538.09% | 6 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $44 | $9.13 | +381.93% | 1 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $69 → $88 | $50.01 | +75.96% | 2 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $1.45 | +175.86% | 5 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 | $1.12 | +1,596.43% | 3 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $1.58 | +2,431.65% | 4 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $27 | $0.65 | +4,034.76% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Hold | $120 | $26.75 | +348.60% | 1 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $100 → $60 | $2.35 | +2,453.19% | 3 | Aug 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $15 | $0.47 | +3,115.43% | 4 | Aug 23, 2022 |
Mersana Therapeutics
May 16, 2025
Maintains: Buy
Price Target: $9 → $10
Current: $0.37
Upside: +2,632.99%
Legend Biotech
May 14, 2025
Maintains: Buy
Price Target: $88 → $71
Current: $28.29
Upside: +150.97%
Allogene Therapeutics
May 14, 2025
Maintains: Buy
Price Target: $14 → $10
Current: $1.14
Upside: +777.19%
Autolus Therapeutics
Apr 1, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $1.65
Upside: +506.06%
Genmab
Mar 11, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $21.19
Upside: +112.36%
Iovance Biotherapeutics
Mar 3, 2025
Maintains: Buy
Price Target: $25 → $15
Current: $1.75
Upside: +757.14%
CARGO Therapeutics
Jan 30, 2025
Downgrades: Hold
Price Target: $32 → $7
Current: $4.14
Upside: +69.29%
Exelixis
Jan 27, 2025
Maintains: Buy
Price Target: $42 → $43
Current: $42.41
Upside: +1.39%
IGM Biosciences
Jan 10, 2025
Maintains: Hold
Price Target: $12 → $2
Current: $1.23
Upside: +62.60%
BioNTech SE
Jan 10, 2025
Initiates: Buy
Price Target: $172
Current: $97.53
Upside: +76.36%
Jan 8, 2025
Initiates: Buy
Price Target: $35
Current: $26.04
Upside: +34.41%
Nov 12, 2024
Maintains: Buy
Price Target: $87 → $136
Current: $61.17
Upside: +122.33%
Nov 8, 2024
Maintains: Hold
Price Target: $83 → $97
Current: $108.44
Upside: -10.55%
Aug 16, 2024
Maintains: Buy
Price Target: $18 → $15
Current: $0.92
Upside: +1,538.09%
Jun 24, 2024
Maintains: Buy
Price Target: $50 → $44
Current: $9.13
Upside: +381.93%
Jun 4, 2024
Maintains: Buy
Price Target: $69 → $88
Current: $50.01
Upside: +75.96%
May 21, 2024
Maintains: Buy
Price Target: $5 → $4
Current: $1.45
Upside: +175.86%
May 16, 2024
Maintains: Buy
Price Target: $19
Current: $1.12
Upside: +1,596.43%
Sep 6, 2023
Reiterates: Buy
Price Target: $40
Current: $1.58
Upside: +2,431.65%
Sep 6, 2023
Reiterates: Buy
Price Target: $27
Current: $0.65
Upside: +4,034.76%
Apr 5, 2023
Reinstates: Hold
Price Target: $120
Current: $26.75
Upside: +348.60%
Aug 23, 2022
Maintains: Hold
Price Target: $100 → $60
Current: $2.35
Upside: +2,453.19%
Aug 23, 2022
Maintains: Buy
Price Target: $19 → $15
Current: $0.47
Upside: +3,115.43%